The total return over the past 12 months is +11.57% vs. +16.94% for the S&P 500. So far it's up +3.09% this year. Includes price appreciation + reinvested dividends.
| Category | 1Y (TTM) | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Price CAGR | +11.57% | +40.06% | +37.24% | N/A | N/A | N/A |
| Total Return CAGR | +11.57% | +40.06% | +37.24% | N/A | N/A | N/A |
| Revenue CAGR | +44.02% | +74.75% | +123.86% | N/A | N/A | N/A |
| Net Income CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| EPS CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Dividends CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
Visualize historical growth rates over rolling horizons. Use the dropdown to select different metric vectors.
Mirum Pharmaceuticals, Inc. (MIRM)
| Year | Start price | End price | MIRM Return | SPY Return | Outperformance |
|---|---|---|---|---|---|
| 2026(YTD) | $78.99 | $81.43 | +3.09% | +14.51% | (11.42%) |
| 2025 | $41.35 | $78.99 | +91.03% | +17.72% | +73.31% |
| 2024 | $29.52 | $41.35 | +40.07% | +24.89% | +15.18% |
| 2023 | $19.50 | $29.52 | +51.38% | +26.19% | +25.19% |
| 2022 | $15.95 | $19.50 | +22.26% | (18.17%) | +40.43% |
| 2021 | $17.46 | $15.95 | (8.65%) | +28.74% | (37.39%) |
| 2020 | $24.52 | $17.46 | (28.79%) | +18.37% | (47.16%) |
Start and end prices are split-adjusted closing prices. Total return includes reinvested dividends, so it can differ from the price change.
